Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
9.32
+0.19 (2.08%)
At close: Mar 9, 2026, 4:00 PM EDT
9.41
+0.09 (0.97%)
After-hours: Mar 9, 2026, 6:54 PM EDT

Seres Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
841421816987652,236
Upgrade
Market Cap Growth
-39.17%-21.59%-74.06%-8.81%-65.78%825.56%
Upgrade
Enterprise Value
1201692235414611,979
Upgrade
Last Close Price
9.1316.6228.00112.00166.60490.00
Upgrade
PE Ratio
15.051043.26----
Upgrade
PS Ratio
235.96---5.2867.31
Upgrade
PB Ratio
1.8310.29-4.0364.715.8212.79
Upgrade
P/TBV Ratio
1.9010.29-64.715.8212.79
Upgrade
P/OCF Ratio
----114.40-
Upgrade
EV/Sales Ratio
343.12---3.1859.60
Upgrade
Debt / Equity Ratio
1.956.65-4.4315.080.370.23
Upgrade
Net Debt / Equity Ratio
0.864.41-1.58-1.74-1.84-1.22
Upgrade
Net Debt / EBITDA Ratio
-0.38-0.52-0.370.114.132.61
Upgrade
Net Debt / FCF Ratio
-1.61-0.41-0.560.0883.912.26
Upgrade
Asset Turnover
0.00---0.420.14
Upgrade
Quick Ratio
2.160.801.302.123.535.67
Upgrade
Current Ratio
2.300.941.782.283.695.79
Upgrade
Return on Equity (ROE)
15.96%---258.04%-42.83%-141.00%
Upgrade
Return on Assets (ROA)
-40.12%-30.43%-34.48%-31.96%-11.55%-23.17%
Upgrade
Return on Capital Employed (ROCE)
-85.40%-123.10%-75.10%-68.40%-23.70%-29.70%
Upgrade
Earnings Yield
6.51%0.10%-62.84%-35.85%-8.57%-3.99%
Upgrade
FCF Yield
-28.22%-105.01%-69.26%-34.20%-0.38%-4.21%
Upgrade
Buyback Yield / Dilution
-19.92%-21.40%-18.44%-17.86%-14.93%-40.85%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.